Clinical Research News
-
Up to six new HBV drugs set to launch by 2027, with China driving market growth, says GlobalData
Clinical Research | News | 0 Comment | 29 May, 2019
Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B vir...Read more
-
Agios's Phase 3 ClarlDHy trial of TIBSOVO meet its primary endpoint
Clinical Research | News | 0 Comment | 28 May, 2019
The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial o...Read more
-
Takeda announces results of Phase 3b VARSITY studies
Clinical Research | News | 0 Comment | 20 May, 2019
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...Read more
-
Study demonstrates Clinical Utility of Liquid Biopsy for Cancer Monitoring
Clinical Research | News | 0 Comment | 17 May, 2019
Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with...Read more
-
Clinical Research | News | 0 Comment | 15 May, 2019
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has c...Read more
-
Promethera Biosciences makes progress in HepaStem development programme
Clinical Research | News | 0 Comment | 09 May, 2019
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...Read more
-
WISE enrolls first patient in pivotal clinical study of novel neuro-electrodes for brain monitoring
Clinical Research | News | 0 Comment | 08 May, 2019
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation,...Read more
-
AstraZeneca’s Calquence phase III ASCEND trial meets positive result
Clinical Research | News | 0 Comment | 08 May, 2019
AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treate...Read more
-
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response
Clinical Research | News | 0 Comment | 08 May, 2019
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...Read more
-
Innovent Biologics, Eli Lilly has announced that IBI301 has met pre-defined primary endpoints
Clinical Research | News | 0 Comment | 08 May, 2019
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse...Read more
-
VolitionRx initiates clinical trial programme in lung cancer
Clinical Research | News | 0 Comment | 08 May, 2019
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...Read more
-
Clinical research is becoming more disintegrated with the influx of data from different sources
Clinical Research | Opinion | 0 Comment | 07 May, 2019
Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical ...Read more
-
Clinical Research | News | 0 Comment | 03 May, 2019
Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide rang...Read more
-
NMPA approves Sinovant's clinical trial application for Derazantinib
Clinical Research | News | 0 Comment | 30 Apr, 2019
Sinovant Sciences has announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the...Read more
-
ACADIA Pharma initiates Ph3 CLARITY Program with Pimavanserin for MDD
Clinical Research | News | 0 Comment | 26 Apr, 2019
ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative ...Read more
-
CMD LLC wins AU$1 million grant award from FightMND
Clinical Research | News | 0 Comment | 18 Apr, 2019
Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therap...Read more
-
Zydus Cadila announces phase III trial of Desidustat
Clinical Research | News | 0 Comment | 17 Apr, 2019
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Inve...Read more
-
CStone Pharmaceuticals announces dosing in Ph III trial for treating adenocarcinoma
Clinical Research | News | 0 Comment | 16 Apr, 2019
CStone Pharmaceuticals has announced that the first patient has been successfully enrolled and dosed in Phase III clinic...Read more
